A new trading day began on Tuesday, with Adc Therapeutics SA (NYSE: ADCT) stock price up 2.01% from the previous day of trading, before settling in for the closing price of $1.99. ADCT’s price has ranged from $1.45 to $6.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 91.46%. Meanwhile, its annual earnings per share averaged 41.93%. With a float of $77.58 million, this company’s outstanding shares have now reached $96.69 million.
Let’s determine the extent of company efficiency that accounts for 162 employees. In terms of profitability, gross margin is 89.36%, operating margin of -196.67%, and the pretax margin is -235.56%.
Adc Therapeutics SA (ADCT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adc Therapeutics SA is 19.76%, while institutional ownership is 69.01%. The most recent insider transaction that took place on Dec 11 ’24, was worth 304,500. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $3.04, taking the stock ownership to the 15,666,731 shares. Before that another transaction happened on Dec 11 ’24, when Company’s 10% Owner bought 100,000 for $3.04, making the entire transaction worth $304,500. This insider now owns 13,145,712 shares in total.
Adc Therapeutics SA (ADCT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.93% per share during the next fiscal year.
Adc Therapeutics SA (NYSE: ADCT) Trading Performance Indicators
Here are Adc Therapeutics SA’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.40, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Adc Therapeutics SA (ADCT)
Looking closely at Adc Therapeutics SA (NYSE: ADCT), its last 5-days average volume was 1.04 million, which is a jump from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 20.89%. Additionally, its Average True Range was 0.31.
During the past 100 days, Adc Therapeutics SA’s (ADCT) raw stochastic average was set at 13.61%, which indicates a significant increase from 13.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 301.69% in the past 14 days, which was higher than the 132.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.5800, while its 200-day Moving Average is $3.3400. However, in the short run, Adc Therapeutics SA’s stock first resistance to watch stands at $2.0700. Second resistance stands at $2.1200. The third major resistance level sits at $2.1800. If the price goes on to break the first support level at $1.9700, it is likely to go to the next support level at $1.9000. Should the price break the second support level, the third support level stands at $1.8600.
Adc Therapeutics SA (NYSE: ADCT) Key Stats
With a market capitalization of 196.28 million, the company has a total of 96,690K Shares Outstanding. Currently, annual sales are 69,560 K while annual income is -240,050 K. The company’s previous quarter sales were 18,460 K while its latest quarter income was -43,970 K.
